Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | CV3X74AO1H |
InChI Key | HPAPGONEMPZXMM-ONAXAZCASA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C38H53N5O9S |
Molecular Weight | 755.93 |
AlogP | 3.67 |
Hydrogen Bond Acceptor | 9.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 180.52 |
Molecular species | ACID |
Aromatic Rings | 1.0 |
Heavy Atoms | 53.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A inhibitor | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Protease
Cysteine protease
Cysteine protease CA clan
Cysteine protease C1A family
|
- | 78000 | - | - | - | |
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | - | - | 0-19 | - | |
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | - | - | 0-19 | - | |
Unclassified protein
|
- | - | - | 22-88 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hepatitis C, Chronic | 3 | D019698 | ClinicalTrials |
Hepatitis C | 2 | D006526 | ClinicalTrials |
Infections | 2 | D007239 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 923590-37-8 |
ChEMBL | CHEMBL599872 |
FDA SRS | CV3X74AO1H |
PubChem | 24765256 |
SureChEMBL | SCHEMBL3263999 |
ZINC | ZINC000096174226 |